# Iranian psychiatrists' attitudes and prescribing patterns toward methamphetamine use disorder: a cross-sectional survey - URL: https://alisanburak.com/en/wcp-2026-posterler/ev1019 - Language: en - Last updated: not specified - Page title: Iranian psychiatrists' attitudes and prescribing patterns toward methamphetamine use disorder: a cross-sectional survey | WCP 2026 Summary > The management of methamphetamine use disorder varies significantly according to physicians' age, practice location, and academic affiliation; mirtazapine and… This page was translated automatically from Turkish. [Read the original](https://alisanburak.com/wcp-2026-posterler/ev1019) This page is an AI-assisted Turkish summary of the study presented at the 26th World Congress of Psychiatry. The study belongs to the presenting authors; please refer to the original source when citing it. EV1019 E-PosterAddictionCross-sectional study # Iranian psychiatrists' attitudes and prescribing patterns toward methamphetamine use disorder: a cross-sectional survey IRANIAN PSYCHIATRISTS' ATTITUDES TOWARD METHAMPHETAMINE USE DISORDER AND PRESCRIBING PATTERNS: A CROSS-SECTIONAL SURVEY Presenter: Sahar SadatSharifi Country: Iran Institution: Iran University of Medical Sciences, School of Medicine, Department of Psychiatry The management of methamphetamine use disorder varies significantly according to physicians' age, practice location, and academic affiliation; mirtazapine and buprenorphine are rarely selected despite supporting evidence. The aim is to describe how methamphetamine use disorder (MUD) is managed across different clinical presentations and the associated variations in practice; the poster states that methamphetamine is the second most commonly used illicit substance in Iran, that no approved pharmacotherapy exists for MUD, and that practice patterns in the country have not previously been mapped. The method is a cross-sectional survey conducted in 2024 using convenience sampling; management preferences were assessed using four expert-validated vignettes, with statistical significance set at p < 0.05; participants were 150 Iranian psychiatrists (58.7% female; 24.0% academic faculty; age 40.8 ± 8.8 years; 47.3% based in Tehran). In the methamphetamine-induced psychosis scenario, 88.0% of participants prescribed medication, and 55.3% selected atypical antipsychotic monotherapy; 45.3% prescribed medication for craving (gabapentinoids 27.9%, bupropion 25.0%), and 50.0% added medication for aggression (sedatives 28.0%, mood stabilizers 20.0%). In the scenario involving resolving acute intoxication, 50.0% prescribed medication and 24.7% considered hospitalization (sedatives, such as benzodiazepines, 28.0%; atypical antipsychotics 26.7%; typical antipsychotics 17.3%). In the cessation scenario involving craving, 66.7% prescribed medication for craving (bupropion 50.0%; bupropion with methylphenidate 16.0%; bupropion with buprenorphine 1.0%); in the presence of dysphoric mood, bupropion was selected by 44.0%, SSRIs by 22.7%, and mirtazapine by 2.7%. For recurrent substance-induced psychosis, 80.0% preferred combined psychotherapy and pharmacotherapy, 10.0% psychotherapy alone, 6.0% medication only during relapse, and 4.0% long-term medication alone; the rate of long-acting injectable antipsychotic use was 35.3%. Significant practice differences were identified by age (decreased use of atypical antipsychotics in older patients, increased use of combined typical and atypical antipsychotics, and medication-only treatment observed exclusively among those under 40), academic faculty status, and practice location (lower use of pharmacotherapy for craving and depot antipsychotics in Tehran). The poster reports as a limitation that vignette responses and convenience sampling may not reflect routine prescribing nationwide. [View the original poster](https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1308) How to cite this study APA 7: SadatSharifi, S., et al. (2026, September 23-26). Iranian psychiatrists' attitudes toward methamphetamine use disorder and prescribing patterns: a cross-sectional survey [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1308 Vancouver: SadatSharifi S, et al. Iranian psychiatrists' attitudes toward methamphetamine use disorder and prescribing patterns: a cross-sectional survey [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1308 Author names and title formatting were generated automatically from the congress system; please check them against the original poster before use. ## On the same topic - [Kannabis kaynaklı psikotik bozuklukta yatışlar ve yeniden yatışlar: retrospektif bir kohort çalışması (2018 ile 2024 arası)](https://alisanburak.com/en/wcp-2026-posterler/ev0001) - [Bağımlılıklarda psikoplasti ve bütünleşik yönetim: ASAM ölçütleri kullanılarak ödül yolağının yeniden biçimlendirilmesine yönelik nörobiyolojik bir algoritma](https://alisanburak.com/en/wcp-2026-posterler/ev0003) - [Slovenya cezaevi hizmetinde depo buprenorfin uygulamasının başlatılması](https://alisanburak.com/en/wcp-2026-posterler/ev0004) - [Bağımlılıklarda metilfenidat: DEHB olan ve olmayan erişkinlerde madde kullanımı ve bağımlılık yapan davranışlara ilişkin gelişen kanıtlar](https://alisanburak.com/en/wcp-2026-posterler/ev0005) - [Malezya'da naltreksonun genişleyen klinik kullanım alanları: madde kullanımı ve madde dışı psikiyatrik bozukluklar açısından çıkarımlar](https://alisanburak.com/en/wcp-2026-posterler/ev0006) [All WCP 2026 summaries](https://alisanburak.com/en/wcp-2026-posterler) --- Kaynak / Source: https://alisanburak.com/en/wcp-2026-posterler/ev1019 İletişim / Contact: Bağdat Caddesi, Veli Güneysu Apt. No:453 K:4 D:9, Suadiye / Kadıköy, İstanbul · +90 532 642 95 25 · info@alisanburak.com · https://alisanburak.com/bagdat-caddesi-psikoterapi-iletisim